research peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilised cake or powder |
| Solubility class | Freely soluble in water | Aqueous buffers also used |
| Typical storage temperature | About -20 degrees Celsius | Dry, sealed and protected from light |
| Typical analytical method | Reversed-phase HPLC or LC-MS/MS | Used for purity, identity and quantification |
| Common synonyms | Thymosin beta-4 fragment | Also listed under fragment-based descriptions |
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
==== Exocytosis ==== Exocytosis is the process by which a cell transports molecules such as neurotransmitters and proteins out of the cell. As an active transport mechanism, exocytosis requires the use of energy to transport material. Exocytosis and its counterpart, endocytosis, the process that brings substances into the cell, are used by all cells because most chemical substances important to them are large polar molecules that cannot pass through the hydrophobic portion of the cell membrane by passive transport. Exocytosis is the process by which a large amount of molecules are released; thus it is a form of bulk transport. Exocytosis occurs via secretory portals at the cell plasma membrane called porosomes. Porosomes are permanent cup-shaped lipoprotein structures at the cell plasma membrane, where secretory vesicles transiently dock and fuse to release intra-vesicular contents from the cell. In the context of neurotransmission, neurotransmitters are typically released from synaptic vesicles into the synaptic cleft via exocytosis; however, neurotransmitters can also be released via reverse transport through membrane transport proteins.
The parish church of St Peter and St Paul stands on Church Road. It was largely destroyed by German bombing on 16 April 1941 and rebuilt in the 1950s incorporating the medieval tower and reusing much of the flint and fragments of the original stone building. The most noteworthy historic building is Bromley College, London Road. The central public open spaces are; Queen's Gardens, Martin's Hill, Church House Gardens, Library Gardens and College Green.
=== Medical management === A significant portion of patients with cholestasis (80%) will experience pruritus at some point during their disease. This is a condition that can severely decrease a patient's quality of life as it can impact sleep, concentration, work ability, and mood. Many treatments exist, but how effective each option is depends on the patient and their condition. Assessment using a scale, such as a visual analogue scale or a 5-D itch scale will be useful to identify an appropriate treatment. Possible treatment options include antihistamines, ursodeoxycholic acid, and phenobarbital. Nalfurafine hydrochloride can also be used to treat pruritus caused by chronic liver disease and was recently approved in Japan for this purpose. Bile acid binding resins like cholestyramine are the most common treatment. Side effects of this treatment are limited and include constipation and bloating. Other commonly used treatments include rifampin, naloxone, and sertraline. In cholestatic liver disease, when bilirubin concentration starts to build up, a deficiency of fat soluble vitamins may also occur. To manage this, doses of vitamin A, D, E, and K are recommended to retain appropriate vitamin levels. Cholestatic liver disease can impact lipids, and possibly lead to dyslipidemia, which may present a risk for coronary artery disease. Statins and fibrates are generally used as lipid lowering therapy to treat patients with cholestatic liver disease. For intrahepatic cholestasis in pregnant women, S-adenosylmethionine has proven to be an effective treatment.
By 1300, Moscow was one of the leading principalities within Vladimir-Suzdal, alongside Tver. On the right bank of the Moskva River—at a distance of eight kilometers (5 mi) from the Kremlin—Daniel founded the first monastery with the wooden church of St. Daniel-Stylite, which is now the Danilov Monastery. Following Daniel's death in 1303, the territory of the principality almost tripled in size, encompassing the entire Moskva River along with its tributaries, which allowed Moscow to become self-sufficient. The principality was also provided with a river network that facilitated trade. Daniel's descendants struggled with the princes of Tver over succession to the grand principality. Yury won recognition as the grand prince from the contemporary Mongol khan in 1318, but Yury lost the title four years later. Ivan I recovered the grand princely throne from Tver after proving himself to be a loyal servant of the khan. Ivan collected tribute for the khan of the Golden Horde from dependent Russian princes, and he used the funds that he acquired to develop Moscow. In addition, the metropolitan of the Russian Church found an ally in Ivan and moved his seat from the nominal capital of Vladimir to Moscow. The foundation of Moscow's first stone church, the Dormition Cathedral, was laid in 1326, and the metropolitan chose to be buried there—an act that confirmed Moscow's status as the spiritual center of Russian Orthodoxy. Masonry building continued in the following years with the construction of additional stone churches.
Sources: en.wikipedia.org
Another champion of the approach of developing chemical analogues of known active substances was Sir David Jack at Allen and Hanbury's, later Glaxo, who pioneered the first inhaled selective beta2-adrenergic agonist for asthma, the first inhaled steroid for asthma, ranitidine as a successor to cimetidine, and supported the development of the triptans. Gertrude Elion, working mostly with a group of fewer than 50 people on purine analogues, contributed to the discovery of the first anti-viral; the first immunosuppressant (azathioprine) that allowed human organ transplantation; the first drug to induce remission of childhood leukemia; pivotal anti-cancer treatments; an anti-malarial; an anti-bacterial; and a treatment for gout. Cloning of human proteins made possible the screening of large libraries of compounds against specific targets thought to be linked to specific diseases. This approach is known as reverse pharmacology and is the most frequently used approach today. In the 2020s, qubit and quantum computing started to be used to reduce the time needed to drug discovery.
== Further reading == Zachara, Natasha; Akimoto, Yoshihiro; Hart, Gerald W. (2015), Varki, Ajit; Cummings, Richard D.; Esko, Jeffrey D.; Stanley, Pamela (eds.), "The O-GlcNAc Modification", Essentials of Glycobiology (3rd ed.), Cold Spring Harbor Laboratory Press, PMID 28876858.
=== MMPs in wound healing === During wound healing, matrix metalloproteinases serve as a cleanup team, breaking down old tissues to make room for new ones. MMP-8 from neutrophils jumps in early to clear debris and accelerate skin healing overall, while MMP-1 from collagenases enhances keratinocyte movement across collagen fibers, helping to begin the repair after injury. MMP-13 then takes over to reduce the size of the wound and initiate re-epithelialization. Faster closure is achieved by drawing the wound edges together. Meanwhile, by activating MMP-9 and directing keratinocytes to migrate into the gap, the gelatinases MMP-2 speed up the healing process, while MMP-9 itself promotes cell migration everywhere within the wound. Based on that, the stromelysins and other MMPs fine-tune the final stages. MMP-3 activates MMP-9 further and helps in the contraction of the wound, preventing scarring or tissue deformation, while MMP-10 secreted by keratinocytes at the wound edges to support the remodeling. MMP-7 ‘s main role is re-epithelialization, going through barriers like elastin and laminin allowing new skin cells to spread out, and MMP-12 manages the angiogenesis by making angiostatin, which controls new blood vessel growth preventing their overgrowth. These MMPs work together to balance the breakdown and rebuild, transforming the damaged tissue into healthy tissue.
== History == In 1974, a four-year-old tomcat with fragile skin was taken to Cornell University's New York State Veterinary College Small Animal Clinic for investigation. Dr DV Scott noted that its skin was exceptionally thin and velvety in texture. It was hyperextensible (extremely stretchy) and had a criss-cross network of fine white scars from previously healed tears. When fur was clipped from a foreleg to gain a blood sample, the skin peeled away. Peeling was found to occur whenever the slightest pressure was applied anywhere to the cat's skin. Investigation showed that the collagen fibres in the cat's skin were abnormal. In 1975, an adult female cat examined by W.F. Butler of Bristol University's Anatomy Department was found to have very fragile skin on its body. It had abnormally low levels of collagen in the skin of its lower back. In 1977, Drs. Donald F. Patterson and Ronald R. Minor of the university of Pennsylvania's School of Veterinary Medicine studied a young short-haired gray tomcat which had severely lacerated its skin through normal scratching. Its skin was found to be delicate and easily torn. It was also abnormally elastic, and the skin of the back could be extended to a distance above the backbone equal to about 22% of the cat's entire body length. They wrote a paper on the subject and included photos of the cat with its skin gently stretched into "wings". Because of the difficulties in caring for a cat with an incurable skin fragility problem, they donated it to the veterinary school.
Collagen alpha-1(XIII) chain is a protein that in humans is encoded by the COL13A1 gene. This gene encodes the alpha chain of one of the nonfibrillar collagens. The function of this gene product is not known, however, it has been detected at low levels in all connective tissue-producing cells so it may serve a general function in connective tissues. Unlike most of the collagens, which are secreted into the extracellular matrix, collagen XIII contains a transmembrane domain and the protein has been localized to the plasma membrane. The transcripts for this gene undergo complex and extensive splicing involving at least eight exons. Like other collagens, collagen XIII is a trimer; it is not known whether this trimer is composed of one or more than one alpha chain isomer. A number of alternatively spliced transcript variants have been described, but the full length nature of some of them has not been determined. Collagen XIII belongs to the transmembranous subfamily of collagens, like collagen XVII, XXIII and XXV.
Sources: en.wikipedia.org
Natural Selection is a modification for the video game Half-Life. Its concept is a mixture of the first-person shooter and real-time strategy game genres. The game was created by Charlie "Flayra" Cleveland, who later founded the company Unknown Worlds Entertainment. Natural Selection v1 was first publicly released on Halloween 2002, and is now at version 3.2. Natural Selection 2 was released in late 2012. The game features two teams: Kharaa (alien species) and Frontiersmen (human space marines). The visible Kharaa "units" are actually simply the spawn of the real Kharaa (aliens) which are microscopic life-forms according to the storyline. The game was, in 2008, one of the ten most played Half-Life modifications in terms of players, according to GameSpy. On January 22, 2014 Unknown Worlds released the source code for download on a GitHub repository under GPLv3.
He plants several bombs on Earth and challenges S.P.D.'s Earth unit to find them as part of a game he played on previous planets before he destroyed them while using his tiny size to hide. After Ban finds him disguised as a walkie-talkie, Byz Goa retaliates by piloting a Kaijuki called Cannon Gladiator 2 (キャノングラディエーター2, Kyanon Guradiētā Tsū), only to be deleted by Dekaranger Robo. Byz Goa is voiced by Tomokazu Seki (関 智一, Seki Tomokazu). Dradian Goldom (ドラド星人ゴルドム, Dorado Seijin Gorudomu): A criminal from Planet Drad who kidnaps Attika Alpachi's son to force him into taking a city block hostage while Goldom robs a nearby bank in the confusion, only for the Dekarangers to realize the truth. Goldom attempts to escape in his Kaijuki, Terrible Terror 2 (テリブルテーラー2, Teriburu Tērā Tsū), but is deleted by Deka Bike Robo. Goldom is voiced by Takaya Kuroda (黒田 崇矢, Kuroda Takaya). Amoreian Baachiyo (アモーレ星人バーチョ, Amōre Seijin Bacho): A hermaphroditic spider-themed criminal and stalker from Planet Amore who possesses four tendrils capable of firing spider silk-like threads to restrain targets and whose people earned a reputation for being overly passionate and "too in love". Following a brief encounter with Tetsu while the officer was working undercover as a woman, falling in love with "her", and eventually metamorphosing from his powerless immature form to his stronger adult form, Baachiyo stalks Swan Shiratori with the belief that she was the person he fell in love with.
Earwigs are not known to purposely climb into external ear canals, though there have been anecdotal reports of earwigs being found in the ear. The name may be a reference to the appearance of their hindwings, which are unique and distinctive among insects, and resemble a human ear when unfolded. Houseflies have an average lifespan of 20 to 30 days, not 24 hours. However, females of the Dolania americana species of mayfly, which do not belong to the group of true flies, have an adult lifespan of as little as 5 minutes. Female praying mantises do not always eat the males during mating. The daddy longlegs spider (Pholcidae) is not the most venomous spider in the world. Their fangs are capable of piercing human skin, but the tiny amount of venom they carry causes only a mild burning sensation for a few seconds. Other species such as harvestmen and crane flies are also called daddy longlegs, and share the misconception of being highly venomous but unable to pierce the skin of humans. People do not swallow large numbers of spiders during sleep. A sleeping person makes noises that warn spiders of danger. Most people also wake up from sleep when they have a spider on their face. Though they are often called "white ants", termites are not ants, nor are they closely related to ants. Termites are actually highly derived cockroaches. Ticks do not jump or fall from trees onto their hosts. Instead, they lie in wait to grasp and climb onto any passing host or otherwise trace down hosts via, for example, olfactory stimuli, the host's body heat, or carbon dioxide in the host's breath.
== Derivative terms and sundry usages == Derivative terms include various adjectival forms such as integumentary (e.g. system), integumental (e.g. integumental glands, "peltate glands, the integument being raised like a bladder due to abundant secretion") and integumented (as opposed to bare). Other illustrative examples of usage occur in the following articles:
=== Biomimetic design and photocatalysis === Some MOF materials may resemble enzymes when they combine isolated polynuclear sites, dynamic host–guest responses, and hydrophobic cavity environment which are characteristics of an enzyme. Some well-known examples of cooperative catalysis involving two metal ions in biological systems include: the diiron sites in methane monooxygenase, dicopper in cytochrome c oxidase, and tricopper oxidases which have analogy with polynuclear clusters found in the 0D coordination polymers, such as binuclear Cu2 paddlewheel units found in MOP-1 and [Cu3(btc)2] (btc=benzene-1,3,5-tricarboxylate) in HKUST-1 or trinuclear units such as {Fe3O(CO2)6} in MIL-88, and IRMOP-51. Thus, 0D MOFs have accessible biomimetic catalytic centers. In enzymatic systems, protein units show "molecular recognition", high affinity for specific substrates. It seems that molecular recognition effects are limited in zeolites by the rigid zeolite structure. In contrast, dynamic features and guest-shape response make MOFs more similar to enzymes. Indeed, many hybrid frameworks contain organic parts that can rotate as a result of stimuli, such as light and heat. The porous channels in MOF structures can be used as photocatalysis sites. In photocatalysis, the use of mononuclear complexes is usually limited either because they only undergo single-electron process or from the need for high-energy irradiation. In this case, binuclear systems have a number of attractive features for the development of photocatalysts.
Sources: en.wikipedia.org
Sealed, dry and protected from light at reduced temperature is the usual laboratory convention. Allowing a cold vial to reach room temperature before opening limits condensation. Repeated opening exposes the powder to moisture and should be minimised.
Reported purity reflects the batch tested, the chromatographic method used and whether an independent laboratory performed the work. Values quoted without method detail or a traceable certificate are difficult to compare directly.
Short peptides are rapidly broken down by proteases and appear at low concentrations in urine, so the detection window is narrow. Sensitive extraction combined with tandem mass spectrometry is typically required.
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.